CTOs on the Move

empowerins

www.empowerins.com

 
empowerins is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Evansville, IN. To find more information about empowerins, please visit www.empowerins.com
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Imaging Healthcare Specialists

Imaging Healthcare Specialists is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Evaluation Group

The Evaluation Group is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ortho Arkansas

Ortho Arkansas is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SickKids

The Hospital for Sick Children (SickKids) is recognized as one of the world’s foremost paediatric health-care institutions and is Canada’s leading centre dedicated to advancing children’s health through the integration of patient care, research and education. Founded in 1875 and affiliated with the University of Toronto, SickKids is one of Canada’s most research-intensive hospitals and has generated discoveries that have helped children globally. Our mission is to provide the best in complex and specialized family-centred care; pioneer scientific and clinical advancements; share expertise; foster an academic environment that nurtures health-care professionals; and champion an accessible, comprehensive and sustainable child health system. SickKids is proud of its vision of Healthier Children. A Better World.

Personal Genome Diagnostics

Personal Genome Diagnostics (PGDx) is a provider of advanced technology solutions based on Next Generation Sequencing (NGS) and related technologies for cancer genome analysis. PGDx has developed proprietary techniques that identify mutations found in a patient`s tumor through noninvasive testing of circulating tumor DNA. This allows for characterization of unique aspects of disease, such as detection and monitoring of cancer, as well as, identification of mechanisms of resistance to targeted therapy. PGDx is CLIA certified for high-complexity molecular testing using whole exome and targeted analysis approaches. Research and custom approaches include whole genome, exome, custom capture, targeted and plasma analysis. PGDx has developed and introduced a number of proprietary methods to study blood and tissue tumor samples, including methods for advanced bioinformatics analysis.